Companies related to organoids

Human Data, Faster.

We are a young international team, inspired by technology, taking Regenerative Medicine to the next level

Committed to advancing science with innovative technologies and expert support.

Animal-free hydrogel system driving 3D biomimicking platforms for precision medicine, cell therapy and biomanufacturing.

An oncology therapeutics company dedicated to resolving cancer’s complexity to power new treatments for patients.

Emulating Human Biology

Human Tissue Models for Better Therapies

Novel approaches to vascular therapy

Pioneering neuropsychiatric & neurological treatments with brain organoids, functional readouts, and AI.

High quality and novel growth factors for stem cell and organoid culture, regenerative medicine and cellular agriculture

Pre-Cure transforms cancer treatment selection powered by multifunctional tumor-on-a-chip & 3D cell culture technology.

The efficient alternative to animal studies

Invitrocue Pte Ltd. | Transforming Bioanalytics

Pioneering neuropsychiatric & neurological treatments with brain organoids, functional readouts, and AI.

We support drug discovery through translational research across oncology and immuno-oncology.

We empower researchers to explore intelligent biological networks by linking them to information technology.

Reducing the gap between Lab and Clinical Trials with Physiological and Pathological Non-Animal Models

Catalyzing drug discovery for women's health in endometriosis and fibroids

Match cancer patients to the right therapies with our automated organoid analysis and digital surrogates.

Revolutionizing neurological drug development

pixl x bio: from cells to pixels to predictions

A research group at the Karolinska Institutet specialising in male reproductive health.

Large Particle Flow Cytometry: analysis, sorting, and imaging

TRANSFORMING CARDIAC DRUG DISCOVERY

Resolving cancer biology through integrated multi-omics.

MIBE is an Integrative Research Institute of the Technical University of Munich.

Akimbo Bio is developing dual CAR/TCR therapies intended for in vivo delivery via lentiviral vectors.

Providing patients with custom cancer treatments. New Options. More Hope.

Re-Defining Medicine for the Coming Generation.

Are your in vitro models truly mirroring in vivo conditions?

The first ever 4D bioreactor

Engineering Tissues to Disrupt Animal Testing & Save Lives